{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:50:21Z","timestamp":1790725821193,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Open Access Publication Funding"],"award-info":[{"award-number":["Open Access Publication Funding"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fresenius Medical Care GmbH, Germany"},{"DOI":"10.13039\/501100001652","name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001652","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Reactive glucose degradation products (GDPs) are formed during heat sterilization of glucose-containing peritoneal dialysis fluids (PDFs) and may induce adverse clinical effects. Long periods of storage and\/or transport of PDFs before use may lead to de novo formation or degradation of GDPs. Therefore, the present study quantified the GDP profiles of single- and double-chamber PDFs during storage. Glucosone, 3-deoxyglucosone (3-DG), 3-deoxygalactosone (3-DGal), 3,4-dideoxyglucosone-3-ene (3,4-DGE), glyoxal, methylglyoxal (MGO), acetaldehyde, formaldehyde, and 5-hydroxymethylfurfural (5-HMF) were quantified by two validated UHPLC-DAD methods after derivatization with <jats:italic>o<\/jats:italic>-phenylenediamine (dicarbonyls) or 2,4-dinitrophenylhydrazine (monocarbonyls). The PDFs were stored at 50\u00a0\u00b0C for 0, 1, 2, 4, 13, and 26\u00a0weeks. The total GDP concentration of single-chamber PDFs did not change considerably during storage (496.6\u2009\u00b1\u200916.0\u00a0\u00b5M, 0\u00a0weeks; 519.1\u2009\u00b1\u200913.1\u00a0\u00b5M, 26\u00a0weeks), but individual GDPs were affected differently. 3-DG (\u2212\u200982.6\u00a0\u00b5M) and 3-DGal (\u2212\u200971.3\u00a0\u00b5M) were degraded, whereas 5-HMF (+\u2009161.7\u00a0\u00b5M), glyoxal (+\u200932.2\u00a0\u00b5M), and formaldehyde (+\u200912.4\u00a0\u00b5M) accumulated between 0 and 26\u00a0weeks. Acetaldehyde, glucosone, MGO, and 3,4-DGE showed time-dependent formation and degradation. The GDP concentrations in double-chamber fluids were generally lower and differently affected by storage. In conclusion, the changes of GDP concentrations during storage should be considered for the evaluation of clinical effects of PDFs.<\/jats:p>","DOI":"10.1038\/s41598-022-08123-1","type":"journal-article","created":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T11:04:40Z","timestamp":1646996680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Degradation and de novo formation of nine major glucose degradation products during storage of peritoneal dialysis fluids"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5104-9603","authenticated-orcid":false,"given":"Sabrina","family":"Gensberger-Reigl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"St\u00fctzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Auditore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Nikolaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3465-4179","authenticated-orcid":false,"given":"Monika","family":"Pischetsrieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"8123_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/089686089301300309","volume":"13","author":"CB Nilsson-Thorell","year":"1993","unstructured":"Nilsson-Thorell, C. B., Muscalu, N., Andren, A. H., Kjellstrand, P. T. & Wieslander, A. P. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit. Dial. Int. 13, 208\u2013213. https:\/\/doi.org\/10.1177\/089686089301300309 (1993).","journal-title":"Perit. Dial. Int."},{"key":"8123_CR2","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.drudis.2016.06.011","volume":"21","author":"M Pischetsrieder","year":"2016","unstructured":"Pischetsrieder, M., Gensberger-Reigl, S., Atzenbeck, L. & Weigel, I. Chemistry and clinical relevance of carbohydrate degradation in drugs. Drug Discov. Today 21, 1620\u20131631. https:\/\/doi.org\/10.1016\/j.drudis.2016.06.011 (2016).","journal-title":"Drug Discov. Today"},{"key":"8123_CR3","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00216-011-5195-9","volume":"401","author":"S Mittelmaier","year":"2011","unstructured":"Mittelmaier, S., Funfrocken, M., Fenn, D., Berlich, R. & Pischetsrieder, M. Quantification of the six major alpha-dicarbonyl contaminants in peritoneal dialysis fluids by UHPLC\/DAD\/MSMS. Anal. Bioanal. Chem. 401, 1183\u20131193. https:\/\/doi.org\/10.1007\/s00216-011-5195-9 (2011).","journal-title":"Anal. Bioanal. Chem."},{"issue":"Suppl 5","key":"8123_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/ndt\/11.supp5.2","volume":"11","author":"A Mahiout","year":"1996","unstructured":"Mahiout, A., Ehlerding, G. & Brunkhorst, R. Advanced glycation end-products in the peritoneal fluid and in the peritoneal membrane of continuous ambulant peritoneal dialysis patients. Nephrol. Dial. Transplant. 11(Suppl 5), 2\u20136. https:\/\/doi.org\/10.1093\/ndt\/11.supp5.2 (1996).","journal-title":"Nephrol. Dial. Transplant."},{"key":"8123_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/ndt\/14.6.1541","volume":"14","author":"K Honda","year":"1999","unstructured":"Honda, K. et al. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol. Dial. Transplant. 14, 1541\u20131549. https:\/\/doi.org\/10.1093\/ndt\/14.6.1541 (1999).","journal-title":"Nephrol. Dial. Transplant."},{"key":"8123_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000374103","volume":"39","author":"B Santamaria","year":"2015","unstructured":"Santamaria, B. et al. Biocompatibility reduces inflammation-induced apoptosis in mesothelial cells exposed to peritoneal dialysis fluid. Blood Purif. 39, 200\u2013209. https:\/\/doi.org\/10.1159\/000374103 (2015).","journal-title":"Blood Purif."},{"key":"8123_CR7","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1093\/ndt\/gfq484","volume":"26","author":"TO Bender","year":"2011","unstructured":"Bender, T. O. et al. Peritoneal dialysis fluids can alter HSP expression in human peritoneal mesothelial cells. Nephrol. Dial. Transplant. 26, 1046\u20131052. https:\/\/doi.org\/10.1093\/ndt\/gfq484 (2011).","journal-title":"Nephrol. Dial. Transplant."},{"key":"8123_CR8","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1093\/ndt\/gfn273","volume":"23","author":"B Santamaria","year":"2008","unstructured":"Santamaria, B. et al. 3,4-Dideoxyglucosone-3-ene as a mediator of peritoneal demesothelization. Nephrol. Dial. Transplant. 23, 3307\u20133315. https:\/\/doi.org\/10.1093\/ndt\/gfn273 (2008).","journal-title":"Nephrol. Dial. Transplant."},{"key":"8123_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1046\/j.1523-1755.2002.00490.x","volume":"62","author":"T Linden","year":"2002","unstructured":"Linden, T., Cohen, A., Deppisch, R., Kjellstrand, P. & Wieslander, A. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int. 62, 697\u2013703. https:\/\/doi.org\/10.1046\/j.1523-1755.2002.00490.x (2002).","journal-title":"Kidney Int."},{"key":"8123_CR10","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1021\/tx500153n","volume":"27","author":"L Distler","year":"2014","unstructured":"Distler, L., Georgieva, A., Kenkel, I., Huppert, J. & Pischetsrieder, M. Structure- and concentration-specific assessment of the physiological reactivity of alpha-dicarbonyl glucose degradation products in peritoneal dialysis fluids. Chem. Res. Toxicol. 27, 1421\u20131430. https:\/\/doi.org\/10.1021\/tx500153n (2014).","journal-title":"Chem. Res. Toxicol."},{"key":"8123_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/089686089501500212","volume":"15","author":"AP Wieslander","year":"1995","unstructured":"Wieslander, A. P. et al. In vitro biocompatibility of a heat-sterilized, low-toxic, and less acidic fluid for peritoneal dialysis. Perit. Dial. Int. 15, 158\u2013164. https:\/\/doi.org\/10.1177\/089686089501500212 (1995).","journal-title":"Perit. Dial. Int."},{"issue":"Suppl. 3","key":"8123_CR12","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1177\/089686080102103S16","volume":"21","author":"J Passlick-Deetjen","year":"2001","unstructured":"Passlick-Deetjen, J. et al. In vitro superiority of dual-chambered peritoneal dialysis solution with possible clinical benefits. Perit. Dial. Int. 21(Suppl. 3), S96-101. https:\/\/doi.org\/10.1177\/089686080102103S16 (2001).","journal-title":"Perit. Dial. Int."},{"key":"8123_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/089686080202200309","volume":"22","author":"T Zimmeck","year":"2002","unstructured":"Zimmeck, T., Tauer, A., Fuenfrocken, M. & Pischetsrieder, M. How to reduce 3-deoxyglucosone and acetaldehyde in peritoneal dialysis fluids. Perit. Dial. Int. 22, 350\u2013356. https:\/\/doi.org\/10.1177\/089686080202200309 (2002).","journal-title":"Perit. Dial. Int."},{"key":"8123_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1177\/089686080502500615","volume":"25","author":"M Erixon","year":"2005","unstructured":"Erixon, M. et al. Take care in how you store your PD fluids: actual temperature determines the balance between reactive and non-reactive GDPs. Perit. Dial. Int. 25, 583\u2013590. https:\/\/doi.org\/10.1177\/089686080502500615 (2005).","journal-title":"Perit. Dial. Int."},{"key":"8123_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/089686080402400415","volume":"24","author":"P Kjellstrand","year":"2004","unstructured":"Kjellstrand, P., Erixon, M., Wieslander, A., Linden, T. & Martinson, E. Temperature: The single most important factor for degradation of glucose fluids during storage. Perit. Dial. Int. 24, 385\u2013391. https:\/\/doi.org\/10.1177\/089686080402400415 (2004).","journal-title":"Perit. Dial. Int."},{"key":"8123_CR16","doi-asserted-by":"publisher","first-page":"6103","DOI":"10.1021\/acs.analchem.5b00665","volume":"87","author":"S Gensberger","year":"2015","unstructured":"Gensberger, S., Knabner, C., Waibel, R., Huppert, J. & Pischetsrieder, M. Qualitative profiling of polyglucose degradation products in peritoneal dialysis fluids. Anal. Chem. 87, 6103\u20136111. https:\/\/doi.org\/10.1021\/acs.analchem.5b00665 (2015).","journal-title":"Anal. Chem."},{"key":"8123_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/pts.968","volume":"25","author":"SP Singh","year":"2012","unstructured":"Singh, S. P., Saha, K., Singh, J. & Sandhu, A. P. S. Measurement and analysis of vibration and temperature levels in global intermodal container shipments on truck, rail and ship. Packag. Technol. Sci. 25, 149\u2013160. https:\/\/doi.org\/10.1002\/pts.968 (2012).","journal-title":"Packag. Technol. Sci."},{"key":"8123_CR18","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/bmc.1194","volume":"23","author":"M Frischmann","year":"2009","unstructured":"Frischmann, M. et al. Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids. Biomed. Chromatogr. 23, 843\u2013851. https:\/\/doi.org\/10.1002\/bmc.1194 (2009).","journal-title":"Biomed. Chromatogr."},{"key":"8123_CR19","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00216-010-4456-3","volume":"399","author":"S Mittelmaier","year":"2011","unstructured":"Mittelmaier, S., Funfrocken, M., Fenn, D. & Pischetsrieder, M. 3-Deoxygalactosone, a new glucose degradation product in peritoneal dialysis fluids: Identification, quantification by HPLC\/DAD\/MSMS and its pathway of formation. Anal. Bioanal. Chem. 399, 1689\u20131697. https:\/\/doi.org\/10.1007\/s00216-010-4456-3 (2011).","journal-title":"Anal. Bioanal. Chem."},{"key":"8123_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/bj3440109","volume":"344","author":"PJ Thornalley","year":"1999","unstructured":"Thornalley, P. J., Langborg, A. & Minhas, H. S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 344, 109\u2013116 (1999).","journal-title":"Biochem. J."},{"key":"8123_CR21","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.1021\/jf9019085","volume":"57","author":"J Gobert","year":"2009","unstructured":"Gobert, J. & Glomb, M. A. Degradation of glucose: Reinvestigation of reactive alpha-dicarbonyl compounds. J. Agric. Food Chem. 57, 8591\u20138597. https:\/\/doi.org\/10.1021\/jf9019085 (2009).","journal-title":"J. Agric. Food Chem."},{"key":"8123_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10719-020-09964-6","volume":"38","author":"S Gensberger-Reigl","year":"2021","unstructured":"Gensberger-Reigl, S., Auditore, A., Huppert, J. & Pischetsrieder, M. Metal cations promote alpha-dicarbonyl formation in glucose-containing peritoneal dialysis fluids. Glycoconj. J. 38, 319\u2013329. https:\/\/doi.org\/10.1007\/s10719-020-09964-6 (2021).","journal-title":"Glycoconj. J."},{"key":"8123_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1177\/089686089701700413","volume":"17","author":"LA Cooker","year":"1997","unstructured":"Cooker, L. A., Luneburg, P., Faict, D., Choo, C. & Holmes, C. J. Reduced glucose degradation products in bicarbonate\/lactate-buffered peritoneal dialysis solutions produced in two-chambered bags. Perit. Dial. Int. 17, 373\u2013378. https:\/\/doi.org\/10.1177\/089686089701700413 (1997).","journal-title":"Perit. Dial. Int."},{"key":"8123_CR24","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1006\/bbrc.2001.4294","volume":"280","author":"A Tauer","year":"2001","unstructured":"Tauer, A. et al. In vitro formation of N(epsilon)-(carboxymethyl)lysine and imidazolones under conditions similar to continuous ambulatory peritoneal dialysis. Biochem. Biophys. Res. Commun. 280, 1408\u20131414. https:\/\/doi.org\/10.1006\/bbrc.2001.4294 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"8123_CR25","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1021\/jf000004n","volume":"48","author":"VA Yaylayan","year":"2000","unstructured":"Yaylayan, V. A. & Keyhani, A. Origin of carbohydrate degradation products in l-alanine\/D-[(13)C]glucose model systems. J. Agric. Food Chem. 48, 2415\u20132419. https:\/\/doi.org\/10.1021\/jf000004n (2000).","journal-title":"J. Agric. Food Chem."},{"key":"8123_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.lwt.2010.11.002","volume":"44","author":"E Capuano","year":"2011","unstructured":"Capuano, E. & Fogliano, V. Acrylamide and 5-hydroxymethylfurfural (HMF): A review on metabolism, toxicity, occurrence in food and mitigation strategies. LWT 44, 793\u2013810. https:\/\/doi.org\/10.1016\/j.lwt.2010.11.002 (2011).","journal-title":"LWT"},{"key":"8123_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.toxlet.2009.10.022","volume":"192","author":"I Severin","year":"2010","unstructured":"Severin, I., Dumont, C., Jondeau-Cabaton, A., Graillot, V. & Chagnon, M.-C. Genotoxic activities of the food contaminant 5-hydroxymethylfurfural using different in vitro bioassays. Toxicol. Lett. 192, 189\u2013194. https:\/\/doi.org\/10.1016\/j.toxlet.2009.10.022 (2010).","journal-title":"Toxicol. Lett."},{"key":"8123_CR28","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0278-6915(00)00070-3","volume":"38","author":"C Janzowski","year":"2000","unstructured":"Janzowski, C., Glaab, V., Samimi, E., Schlatter, J. & Eisenbrand, G. 5-Hydroxymethylfurfural: Assessment of mutagenicity, DNA-damaging potential and reactivity towards cellular glutathione. Food Chem. Toxicol. 38, 801\u2013809. https:\/\/doi.org\/10.1016\/S0278-6915(00)00070-3 (2000).","journal-title":"Food Chem. Toxicol."},{"key":"8123_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/em.21963","volume":"56","author":"AH H\u00f8ie","year":"2015","unstructured":"H\u00f8ie, A. H. et al. Genotoxicity of three food processing contaminants in transgenic mice expressing human sulfotransferases 1A1 and 1A2 as assessed by the in vivo alkaline single cell gel electrophoresis assay. Environ. Mol. Mutagen. 56, 709\u2013714. https:\/\/doi.org\/10.1002\/em.21963 (2015).","journal-title":"Environ. Mol. Mutagen."},{"key":"8123_CR30","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/carcin\/15.10.2375","volume":"15","author":"Y-J Surh","year":"1994","unstructured":"Surh, Y.-J., Liem, A., Miller, J. A. & Tannenbaum, S. R. 5-Sulfooxymethylfurfural as a possible ultimate mutagenic and carcinogenic metabolite of the Maillard reaction product, 5-hydroxymethylfurfural. Carcinogenesis 15, 2375\u20132377. https:\/\/doi.org\/10.1093\/carcin\/15.10.2375 (1994).","journal-title":"Carcinogenesis"},{"key":"8123_CR31","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.1021\/jf403098y","volume":"61","author":"L Zhao","year":"2013","unstructured":"Zhao, L. et al. In vitro antioxidant and antiproliferative activities of 5-hydroxymethylfurfural. J. Agric. Food Chem. 61, 10604\u201310611. https:\/\/doi.org\/10.1021\/jf403098y (2013).","journal-title":"J. Agric. Food Chem."},{"key":"8123_CR32","unstructured":"Bundesinstitut f\u00fcr Risikobewertung. 5-HMF-Gehalte in Lebensmitteln sind nach derzeitigem wissenschaftlichen Kenntnisstand gesundheitlich unproblematisch. Stellungnahme des BfR 030\/2011. Accessed 31 January 2022."},{"key":"8123_CR33","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1681\/ASN.V114729","volume":"11","author":"J Witowski","year":"2000","unstructured":"Witowski, J. et al. Effect of glucose degradation products on human peritoneal mesothelial cell function. J. Am. Soc. Nephrol. 11, 729. https:\/\/doi.org\/10.1681\/ASN.V114729 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"8123_CR34","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1046\/j.1523-1755.2003.00265.x","volume":"64","author":"LW Morgan","year":"2003","unstructured":"Morgan, L. W. et al. Glucose degradation products (GDP) retard remesothelialization independently of d-glucose concentration. Kidney Int. 64, 1854\u20131866. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00265.x (2003).","journal-title":"Kidney Int."},{"key":"8123_CR35","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.jchromb.2010.02.004","volume":"878","author":"S Mittelmaier","year":"2010","unstructured":"Mittelmaier, S., Funfrocken, M., Fenn, D., Fichert, T. & Pischetsrieder, M. Identification and quantification of the glucose degradation product glucosone in peritoneal dialysis fluids by HPLC\/DAD\/MSMS. J. Chromatogr. B 878, 877\u2013882. https:\/\/doi.org\/10.1016\/j.jchromb.2010.02.004 (2010).","journal-title":"J. Chromatogr. B"},{"key":"8123_CR36","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1007\/s00216-012-5817-x","volume":"403","author":"S Gensberger","year":"2012","unstructured":"Gensberger, S., Mittelmaier, S., Glomb, M. A. & Pischetsrieder, M. Identification and quantification of six major alpha-dicarbonyl process contaminants in high-fructose corn syrup. Anal. Bioanal. Chem. 403, 2923\u20132931. https:\/\/doi.org\/10.1007\/s00216-012-5817-x (2012).","journal-title":"Anal. Bioanal. Chem."},{"key":"8123_CR37","unstructured":"European Medicines Agency. ICH Topic Q 1 A (R2) Stability Testing of New Drug Substances and Products. EMEA CPMP\/ICh\/2736\/99. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q-1-r2-stability-testing-new-drug-substances-products-step-5_en.pdf (2003)."},{"key":"8123_CR38","doi-asserted-by":"publisher","unstructured":"DIN (German National Standards). DIN 32645:2008\u20132011: Chemical Analysis: Decision Limit, Detection Limit and Determination Limit Under Repeatability Conditions: Terms, Methods, Evaluation. https:\/\/doi.org\/10.31030\/1465413 (Deutsches Institut f\u00fcr Normung e.V., 2008).","DOI":"10.31030\/1465413"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08123-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:31:56Z","timestamp":1669336316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-08123-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8123"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-08123-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The coauthor T.N. is employed by Fresenius Medical Care, a company producing dialysis fluids. The study received financial research support by Fresenius Medical Care. Although very unlikely, it cannot be fully excluded that the results of the publication influence the company\u00b4s sales numbers. T.N. participated in study design, provided sample material, and conducted sample storage. GDP analysis and interpretation of data was carried out by S.G.-R., I.W., J.S., A.A., and M.P., respectively.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4268"}}